carboplatin
Retrospective analysis of carboplatin-induced cumulative ...
In conclusion, the incidence of carboplatin-induced cumulative neutropenia after 4 to 6 doses of carboplatin monotherapy is low in cancer- ...
Patient information - Breast cancer metastatic - Carboplatin - eviQ
Patient information - Breast cancer metastatic - Carboplatin. Your treatment. The treatment schedule below explains how the drug for this treatment is given.
Efficacy and safety of carboplatin with nab-paclitaxel versus ...
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, ...
Carboplatin [Specialist drug] - BNF - NICE
NICE TA284 Bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer (May 2013)
Carboplatin: molecular mechanisms of action associated ... - SciELO
In this narrative review, we discuss some of the known mechanisms of resistance to platinum-based drugs, especially carboplatin.
Carboplatin Injection - Pfizer Hospital US
Add Customer Account Number ... By providing your email address and/or phone number, you are agreeing to receive transactional, product, supply information ...
Carboplatin: Chemotherapy for breast cancer | LBBC
Carboplatin may be used to treat metastatic breast cancer. It can also be used with the chemotherapy medicines docetaxel (Taxotere) or paclitaxel (Taxol) and ...
What are some common side effects of this medication? ... About 6 to 12 hours after treatment, nausea and vomiting may be experienced, which may recur over the ...
Gemcitabine and carboplatin 322 - Velindre University NHS Trust
Approximately 20% of patients may experience flu like symptoms in the first 48 hours following gemcitabine treatment. This is usually mild and short lived.
Carboplatin - Chemotherapy Drugs - Mesothelioma Guide
Carboplatin is a chemotherapy drug similar to cisplatin. It is often used for pain relief purposes and extending and improving quality of ...
Carboplatin Single-Protocol-CRP09-GY002 v1 3 ... 500/250ml 5% Glucose over. 30 to 60 Minutes. *Ondansetron IV must be infused over 15 minutes in patients over 65 ...
carboplatin - MHA - Michigan Health & Hospital Association
The two drugs, carboplatin and cisplatin, are used to treat several types of cancer, including bladder, lung, ovarian and testicular cancers. The shortage is ...
If the platelet level falls below 50x109/L reduce the dose by 50%. Hepatic Impairment. Drug. Recommendation. Carboplatin. No dose reduction ...
Utility of carboplatin therapeutic drug monitoring for the treatment of ...
Conclusions. The current study highlights the benefit of delivering carboplatin to infants with retinoblastoma using a real-time TDM approach.
Regimen details. Day. Drug. Dose. Route. 1. Paclitaxel. 175mg/m². IV infusion. 1. Carboplatin. AUC 5 or 6*. IV infusion. * Carboplatin dose calculated using ...
Efficacy of Carboplatin and Isotretinoin in Children With High-risk ...
The addition of carboplatin during radiotherapy improved survival from 54% to 73% only for children with high-risk group 3 medulloblastoma.
Regimen details. Day. Drug. Dose. Route. 1. Paclitaxel. 175mg/m². IV infusion. 1. Carboplatin. AUC 5 or 6*. IV infusion. * Carboplatin dose calculated using ...
Paclitaxel plus carboplatin versus standard chemotherapy with ...
Considering the upper and lower 95% CIs, reasonable maximum possible benefits for progression-free and overall survival are 5% and 4%, respectively, in favour ...
Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial
Intraperitoneal carboplatin resulted in a modest prolongation of PFS when given with dose-dense weekly paclitaxel regardless of residual tumor size.
3505-Breast metastatic cARBOplatin - eviQ
This protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted ...
Carboplatin
MedicationCarboplatin, sold under the brand name Paraplatin among others, is a chemotherapy medication used to treat a number of forms of cancer. This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is used by injection into a vein. Side effects generally occur. Common side effects include low blood cell levels, nausea, and electrolyte problems. Other serious side effects include allergic reactions and mutagenesis. It may be carcinogenic, but further research is needed to confirm this. Use during pregnancy may result in harm to the baby.
carboplatin
DrugTCH
TCH is a chemotherapy regimen consisting of Taxotere, carboplatin and Herceptin, which is used to treat breast cancer.